News
Media And Political Bulletin – 12 May 2020
Media and Political Bulletin 12 May 2020
Government guidance published to help ensure workplaces are as safe as possible. The government, in consultation with industry, has published guidance to help employers, employees and the self-employed understand how to work safely during the coronavirus pandemic. There are 8 guides, which cover a range of different types of work, notably:
|
Media Summary |
Ranitidine 50mg/2ml injection out of supply from May Dispensing Doctors’ Association, Ailsa Colquhoun, 11 May 2020 Dispensing Doctors’ Association reports that Ranitidine 50mg/2ml injection is anticipated to be unavailable from the end of May 2020 until further notice. This is due to on-going regulatory investigations into the presence of the contaminant, N-nitrosodimethylamine (NDMA). At present, in Europe all suppliers of Ranitidine’s active ingredient have had their Certificate of Suitability (CEP) suspended. Therefore, until regulatory investigations are complete, no further supplies of ranitidine products can be manufactured. View the supply disruption alert for clinical advice on alternatives of ranitidine preparations for adults and children.
|
Parliamentary Coverage |
There was no parliamentary coverage today.
|
Full Coverage |
Ranitidine 50mg/2ml injection out of supply from May Dispensing Doctors’ Association, Ailsa Colquhoun, 11 May 2020 Ranitidine 50mg/2ml injection is anticipated to be unavailable from the end of May 2020 until further notice. Ranitidine film-coated tablets, effervescent tablets and oral solution continue to remain unavailable with no date for resupply. This is due to on-going regulatory investigations into the presence of the contaminant, N-nitrosodimethylamine (NDMA). Clinical advice on alternatives of ranitidine preparations for adults and children has been shared in the previous supply disruption alert. View the alert. |
